Examples include TUBB2A which is targeted in PS and RA and others such as BCL6, NR4A2, DUSP10, NAPEPLD, PFKFB3, SRGN, SOCS3 and SOCS1 which also exhibit differences between UC and non-IBD controls. This evidence concerns the gene SRGN and inflammatory bowel disease.